Abstract:ID 99907 Poster Board 509 Radiation poses a serious threat to active-duty military personnel, causing a multitude of health problems for those who are exposed, including the potential for radiation-induced cognitive decline. Recent studies have shown that metformin–an antidiabetic drug–could attenuate the cognitive decline following radiotherapy for brain tumors. Our study tested the hypothesis that metformin prophylaxis would attenuate the central nervous system (CNS) effects of a whole-body non-lethal radiation exposure dose more representative of an exposure military personnel might encounter. Female Long-Evans rats were injected with metformin (200 mg/kg per day) for 7 days prior to exposure to gamma radiation (2 Gy; 0.6 Gy/m) using the AFRRI high level cobalt facility. At 2 days following radiation exposure, the effects of metformin prophylaxis were assessed on serum chemistry, hematological endpoints, blood hormone levels, and markers of cell proliferation and neuroinflammation in different brain regions. In a separate group of rats, a behavioral battery was assessed from 7-30 days following radiation exposure, assessing recognition and spatial memory, and anxiety-like and depressive-like behaviors. Following behavioral testing, serum chemistry, hematological endpoints, and makers of cell proliferation and neuroinflammation in different brain regions were assessed. At the 2-day time point, 2 Gy gamma radiation significantly decreased white blood cells, lymphocytes, monocytes, and reticulocytes, with no effect of metformin. Metformin did prevent the radiation-induced decrease in uric acid at this time point. Further, metformin administration appears to have prevented the radiation-induced decrease in lactate, as well, but this effect did not achieve significance. At the 30-day time point, metformin administration significantly increased recovery of reticulocytes. We found a significantly decreased Glu/Gla osteocalcin ratio at 2 days following radiation in the metformin + radiation group compared to sham control. At 30 days following radiation exposure, there was a significant effect of radiation on the Glu/Gla osteocalcin ratio, with radiation exposure resulting in a significant decrease in this ratio compared to sham control rats. This suggests that the Glu/Gla osteocalcin ratio is potentially a biomarker of radiation exposure. Rats receiving metformin prophylaxis showed faster habituation in the open field test compared to all other groups. Taken together, metformin shows potential as prophylaxis for radiation-induced changes following a non-lethal dose of gamma radiation. Intramural funds (AFR-B2-12672) from the Armed Forces Radiobiology Research Institute.

Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells

Metformin Protects Against Radiation-Induced Pneumonitis and Fibrosis and Attenuates Upregulation of Dual Oxidase Genes Expression

Metformin Increases the Radiosensitivity of Non-Small Cell Lung Cancer Cells by Destabilizing NRF2

Radioprotective effect of the anti-diabetic drug metformin

Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization

Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy

Sensitizing effect and Mechanism of metformin on radiotherapy of lung carcinoma A549 cells

Pretreatment with metformin protects mice from whole-body irradiation

Metformin as a Potential Countermeasure for the Central Nervous System Effects of Radiation Exposure

Metformin Sensitizes Prostate Cancer Cells to Radiation Through EGFR/p-DNA-PKCS in Vitro and in Vivo.

Exploring the Potential of Metformin in Mitigating Radiation-induced Gastrointestinal and Hematopoietic System Injury in Rats After Whole-body X-ray Radiation: An Experimental Study

Metformin Enhances Radiation Response of ECa109 Cells Through Activation of ATM and AMPK

Effects of metformin on intestinal barrier repair in radiation proctitis and its mechanism

Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts

Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3

Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair

Metformin Fights Against Radiation-Induced Early Developmental Toxicity.

Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair.

Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2

Metformin Sensitizes Cisplatin-induced Apoptosis Through Regulating Nucleotide Excision Repair Pathway in Cisplatin-resistant Human Lung Cancer Cells

Metformin Radiosensitizing Effect on Hypoxic Oral Squamous Cell Carcinoma Cells by GAPDH and TAGLN2